[Previous Months][Date Index][Thread Index][Join - Register][Login]
[Message Prev][Message Next][Thread Prev][Thread Next]

[IP] FWD: E-News 30-Apr-2000

>===== Original Message From "Dr. Joe" <email @ redacted> =====
Continuous sensing of glucose will enhance the use of
external pumps.  This technology is virtually a
requirement for internal pumps.

Cygnus (glucowatch)  now is down to only one
calibration for 12 hours with 3 measurements/hour.

MiniMed's implantable glucose sensor was said to be
clinically best.  One measurement every 5 minutes with
calibration once daily.  Best at seeing nocturnal glucose

NAS (Portland OR) is invasive with work from people in
Kansas and Paris, France.   Good seven day results.

University of Ulm (Sweden) uses a tissue glucose
method that has now been licensed to Boehringer for
continuous monitoring development.

Disetronic the major insulin pump manufacturer  in
Europe leads a consortium of 6 countries to develop
and refine their system.

Tomorrow "transplantation tolerance"

Dr. Joe, the Diabetes Doctor

Visit our web site at http://www.diabeteswell.com

 This message sent to you from the desk of
  Yerachmiel Bruchya haLevi Altman's computer.

for HELP or to subscribe/unsubscribe, contact: HELP@insulin-pumpers.org
send a DONATION http://www.Insulin-Pumpers.org/donate.shtml